Intended for healthcare professionals

A patient’s experience of biologicals for psoriasis

Jane was 52 years old and had suffered from psoriasis since the age of three. She had seen many doctors and had received many treatments for her severe skin disease. No treatments had been effective without producing significant side-effects. She fulfilled the severity criteria to start biological therapy – her baseline Psoriasis Area and Severity Index (PASI) was 21 and her Dermatology Life Quality Index (DLQI) was 26.
Dermatology in practice 2006; 14(4): 10–12
To continue reading this article, please sign in or register.